The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR

Autor: Pfisterer, J. *, du Bois, A., Sehouli, J., Loibl, S., Reinartz, S., Reuß, A., Canzler, U., Belau, A., Jackisch, C., Kimmig, R., Wollschlaeger, K., Heilmann, V., Hilpert, F.
Zdroj: In Annals of Oncology October 2006 17(10):1568-1577
Databáze: ScienceDirect